Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference

Cancer Gene Therapy
Alexandra StegeHermann Lage

Abstract

Multidrug resistance (MDR) is the major cause of failure of effective chemotherapeutic treatment of disseminated neoplasms. The "classical" MDR phenotype of human malignancies is mediated by drug extrusion by the adenosine triphosphate binding cassette (ABC)-transporter P-glycoprotein (MDR1/P-gp). For stable reversal of "classical" MDR by RNA interference (RNAi) technology, an H1-RNA gene promoter-driven expression vector encoding anti-MDR1/P-gp short hairpin RNA (shRNA) molecules was constructed. By introduction of anti-MDR1/P-gp shRNA expression vectors into the extremely high drug-resistant human gastric carcinoma cell line EPG85-257RDB, the MDR phenotype was completely reversed. The reversal of MDR was accompanied by a complete suppression of MDR1/P-gp expression on mRNA and protein level, and by a considerable increased intracellular anthracyline accumulation in the anti-MDR1/P-gp shRNA-treated cells. The data indicate that stable shRNA-mediated RNAi can be tremendously effective in reversing MDR1/P-gp-mediated MDR and is therefore a promising strategy for overcoming MDR by gene therapeutic applications.

References

Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
Apr 18, 2002·Genes & Development·Patrick J PaddisonDouglas S Conklin
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Guangchao SuiYang Shi
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jenn-Yah YuDavid L Turner
May 1, 2002·Nature Biotechnology·Cynthia P PaulDavid R Engelke
Jun 28, 2002·Nature·Jean-Marc JacqueMario Stevenson
Jun 29, 2002·RNA·Michael T McManusPhillip A Sharp
Jul 12, 2002·Nature·Gregory J Hannon
Oct 3, 2002·Nature Reviews. Genetics·Michael T McManus, Phillip A Sharp
Apr 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Hilary Thomas, Helen M Coley
May 3, 2003·Journal of Experimental Therapeutics & Oncology·John A Kellen
Sep 19, 2003·International Journal of Antimicrobial Agents·Hermann Lage
Oct 25, 2003·Oncogene·Suresh V AmbudkarMichael M Gottesman
Oct 31, 2003·Journal of Medicinal Chemistry·Jacques Robert, Christian Jarry

❮ Previous
Next ❯

Citations

Oct 13, 2009·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Lili Yu, Zehua Wang
May 24, 2005·Pharmacology & Therapeutics·Ray K M Leung, Paul A Whittaker
Sep 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ulrike SteinHermann Lage
Aug 6, 2010·Biological & Pharmaceutical Bulletin·Shujun LiGuisheng Qian
Sep 3, 2010·Journal of Visualized Experiments : JoVE·Hermann Lage, Andrea Krühn
Apr 1, 2011·Therapeutic Delivery·Hermann Lage, Johannes H Fruehauf
Mar 14, 2014·Pharmaceutical Research·João G MarquesIlídio J Correia
Aug 5, 2008·Neurochemical Research·Lei ChenDong Zhou
Aug 1, 2011·Drug Delivery and Translational Research·Tatsuaki TagamiHiroshi Kiwada
May 16, 2009·Expert Opinion on Therapeutic Patents·Derek M Dykxhoorn
Jan 6, 2006·Drug Metabolism Reviews·Xianbin TianKim L R Brouwer
Jul 24, 2007·Cancer Letters·Alex Lyakhovich, Jordi Surralles
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Verena MaternaHermann Lage
Mar 21, 2007·Journal of Cellular Biochemistry·Hui LvZhuchu Chen
Aug 1, 2006·Biochemical and Biophysical Research Communications·Verena MaternaHermann Lage
Aug 25, 2005·Veterinary Parasitology·Georg von Samson-Himmelstjerna, William Blackhall
Apr 10, 2007·Biochemical and Biophysical Research Communications·Alexander KaszubiakHermann Lage
Mar 10, 2016·Journal of Nanobiotechnology·Sten Friberg, Andreas M Nyström
Jul 28, 2016·Expert Opinion on Drug Delivery·Abhirup MandalAshim K Mitra
Jan 10, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Wei ZhangIsmael J Hidalgo
Jun 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrea PichlerDavid Piwnica-Worms
Nov 5, 2019·Biochimica Et Biophysica Acta. Biomembranes·Sundar ThangapandianEmad Tajkhorshid

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.